Bayesian Capital Management’s Braze BRZE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-24,004
Closed -$683K 176
2025
Q3
$683K Buy
+24,004
New +$681K 0.14% 220
2025
Q2
Sell
-18,400
Closed -$664K 565
2025
Q1
$664K Buy
+18,400
New +$740K 0.11% 246
2024
Q3
Sell
-29,341
Closed -$1.14M 711
2024
Q2
$1.14M Buy
+29,341
New +$1.17M 0.13% 205
2024
Q1
Sell
-21,800
Closed -$1.16M 799
2023
Q4
$1.16M Buy
21,800
+5,900
+37% +$292K 0.12% 205
2023
Q3
$743K Sell
15,900
-7,500
-32% -$330K 0.08% 273
2023
Q2
$1.02M Buy
+23,400
New +$795K 0.11% 250
2022
Q3
Sell
-10,106
Closed -$366K 717
2022
Q2
$366K Buy
+10,106
New +$369K 0.07% 416

Other funds holding BRZE

Bayesian Capital Management's BRZE Position: Q4 2025 in Review

Bayesian Capital Management sold out of Braze (BRZE) in Q4 2025, closing a stake of 24,004 shares — an estimated $683K sold.

Bayesian Capital Management first reported a position in BRZE in Q2 2022 and held it in 7 quarters. The position peaked at $1.16M in Q4 2023. 259 funds tracked by Wall St. Rank hold BRZE as of Q4 2025.

  • Bayesian Capital Management reported no remaining Braze position as of Q4 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 24,004 Braze shares in Q4 2025, an estimated $683K.
  • Bayesian Capital Management first reported a position in Braze in Q2 2022 and held it in 7 quarters.
  • Bayesian Capital Management's Braze position peaked at $1.16M in Q4 2023.
  • 259 funds tracked by Wall St. Rank held Braze as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.